Shanghai experts lead the release of the "Chinese Expert Consensus on Peripheral Intervention via Radial Artery Approach", filling a gap in treatment in China | Field | Chinese Expert Consensus on Peripheral Intervention via Radial Artery Approach "

Release time:Apr 14, 2024 02:56 AM

The 14th China Cancer Intervention and Minimally Invasive Treatment Conference and the 8th Asia Pacific Cancer Intervention Conference held today announced that the "Chinese Expert Consensus on Peripheral Intervention through the Radial Artery" led by the Interventional Department of Zhongshan Hospital affiliated with Fudan University has been officially released, which will effectively fill the gap in the field of interventional diagnosis and treatment in China.

What is intervention? Experts explain that under the guidance and monitoring of imaging equipment, puncture needles, catheters, and other interventional devices are used to guide specific instruments into the affected area of the human body through natural pores or small wounds for minimally invasive treatment. In recent years, interventional therapy has been widely known for its advantages of minimally invasive, efficient, and precise treatment. However, traditional peripheral intervention surgery often uses the femoral artery approach, which requires strict immobilization of the lower limbs for 6 hours and bed rest for at least 12 hours after surgery, causing inconvenience to patients. Improving the postoperative patient experience has become one of the urgent clinical challenges that need to be addressed.

Professor Yan Zhiping, the chairman of the conference and director of the Interventional Department of Zhongshan Hospital, introduced that over the past 10 years, clinical research has shown that compared to the more commonly used femoral artery approach in peripheral intervention surgery, the radial artery approach is safer and the postoperative recovery is faster. This is because the radial artery is located superficially and there are no important nerves or blood vessels around it, which can reduce the risk of puncture related complications. Even if bleeding occurs at the puncture site, it can be detected and treated earlier, and postoperative hemostasis and monitoring are also easy.

Professor Yan Zhiping, as the Chairman of the Cancer Intervention Professional Committee of the China Anti Cancer Association, organized a working group of national intervention experts in 2022. After more than a year of careful consideration, polishing, and multiple discussions and revisions, the final draft was officially finalized in March 2023. The consensus fully summarizes the clinical application experience of radial artery approach in peripheral intervention diagnosis and treatment in recent years, providing unified treatment and operational standards for clinical doctors, filling the gap in this field in China, and allowing more patients to benefit from it.

Expert supplement: The anatomical characteristics of the ulnar artery, radial artery, and dual arterial blood supply in the hand, and the occlusion of the radial artery leading to blood supply obstruction, mostly do not seriously affect the blood supply in the hand. The radial artery approach can improve the management of postoperative eating, defecation, and pain in patients, avoiding the problem of prolonged lower limb immobilization increasing the risk of deep vein thrombosis in the lower limbs. Patients generally have a good response.

After more than 10 years of development, the China Cancer Intervention and Minimally Invasive Therapy Conference has become one of the most influential academic platforms in the field of cancer intervention and minimally invasive therapy in China. This year's conference has established 34 specialized sub forums, attracting more than 400 domestic and foreign experts and professors, focusing on the latest achievements and future research directions in tumor intervention and minimally invasive treatment.

Professor Gu Jianying, Secretary of the Party Committee of Zhongshan Hospital, stated that as a pilot hospital for high-quality development of public hospitals and one of the first batch of comprehensive national medical centers, it has actively promoted the upgrading of medical equipment through medical industry cooperation for many years. This year, the Interventional Surgery Department will also add 3 DSA operating rooms and 3 DSA devices including CT-DSA all-in-one machines, promoting the era of intelligent and precise diagnosis and treatment in interventional surgery.

Professor Fan Jia, academician of the Chinese Academy of Sciences and director of Zhongshan Hospital, introduced that Zhongshan Hospital carries out nearly 60000 types of interventional surgeries every year, of which more than 20000 cases are minimally invasive interventional treatments for tumors. In the future, hospitals will focus on research and development in areas such as treatment technology, innovative drugs, medical devices, and medical equipment, to solve key core technologies such as "one stop at the door" and "bottleneck", and strive to build a national intervention and radiation therapy clinical research center.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended